Financial Prediction for The Cooper Companies, Inc. (COO)

COO – Trading Sideways Expected (5-day)

The Cooper Companies, Inc. operates in contact lenses (CooperVision) and women’s health (CooperSurgical). Current price $67.34, market cap $13.14B.

Mixed sentiment, overbought RSI, and a minor guidance cut point to sideways movement in the near term.

Why This Matters

COO is a mid-cap healthcare supplier with a high P/E (33.5) and recent earnings beat, but deteriorating margins and a lowered revenue outlook create uncertainty.

Key Insights

• RSI at 75.31 indicates overbought conditions, suggesting limited upside in the short term.
• Full-year revenue guidance was trimmed by ~0.7% ($4.33B to $4.30B), a minor cut but negative for sentiment.
• Operating margin collapsed to -2.9% in the latest quarter from 18.4% a year ago, signaling operational stress.
• Analyst consensus remains ‘Buy’ with an average target of $87.14, but Needham lowered its target from $101 to $86 on June 4.
• Insider buying by the CEO in late 2025 at $80.80 provides a floor, but the stock is now 17% below that level.

Catalyst Analysis

No immediate catalyst with 5%+ potential is identified. The next earnings report is not until September 2026. The only near-term event is the analyst downgrade (Needham), which is already priced in. The guidance cut is too small to drive a 5% move. Therefore, the 5% catalyst rule forces a ‘sideways’ prediction. A 5-day horizon is chosen because no medium-term catalyst exists to justify a 21-day view.

Signal Contradictions

Several contradictions exist: (1) RSI > 70 (overbought) vs. mixed/neutral news sentiment – technicals suggest a pullback, but news lacks a clear bearish trigger. (2) Revenue grew 5.06% YoY, yet net income fell 4.44% – profitability is declining despite top-line growth. (3) Analyst consensus is ‘Buy’ with a high average target, but the stock is down 17.84% YTD and the latest analyst action was a price target cut. These contradictions reduce confidence to a maximum of 6/10.

Margin & Efficiency Analysis

Gross margin is 65.54%, net margin is 9.16% – a gap of 56.38 percentage points. While revenue is growing (5.06%), the gap is extremely wide, indicating high operating expenses relative to gross profit. The latest quarterly operating margin turned negative (-2.9%), confirming operational inefficiency. This supports a bear case and limits upside potential.

Practical Implications

• Bull Case: The company beat earnings estimates by 7.47% last quarter. CEO insider buying at $80.80 signals confidence. Analyst consensus remains ‘Buy’ with a target 29% above current price. CooperVision holds 25% of the US contact lens market, providing a stable revenue base.
• Bear Case: RSI is overbought (75.31), suggesting a near-term pullback. Revenue guidance was cut, and operating margin turned negative. Net income declined YoY. The stock is down 17.84% YTD, and the latest analyst action was a price target reduction. High P/E (33.5) leaves little room for error.
• Sideways Risk: High. The stock is caught between overbought technicals and a lack of fresh catalysts. The mixed sentiment (67% mixed, 33% neutral) and stale news (one article 119 days old) reinforce indecision. The 5% catalyst rule mandates a sideways prediction, and the contradictions further reduce conviction.
• Confidence: 4/10 – Confidence is 4/10. Reasons: (1) One news article is 119 days old, reducing overall timeliness. (2) Sentiment is mixed/neutral with no clear directional bias. (3) RSI > 70 contradicts any bullish prediction. (4) No 5%+ catalyst exists, forcing a sideways prediction by rule. (5) Contradictions between revenue growth and earnings decline, and between analyst consensus and recent price action, lower confidence. (6) The margin gap is extreme, adding risk. (7) However, the stock is below the average analyst target, and the CEO bought shares, providing some support.

Prediction (5-day): sideways

---

Analysis Metadata:

• News Collection: 2026-06-05
• Analysis Date: 2026-06-05
• Target Date: 2026-06-10

References:

• https://finance.yahoo.com/quote/COO/
• https://finviz.com/stock?t=COO
• https://www.tradingview.com/symbols/NASDAQ-COO/